<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04714775</url>
  </required_header>
  <id_info>
    <org_study_id>BANON2</org_study_id>
    <nct_id>NCT04714775</nct_id>
  </id_info>
  <brief_title>Biomarkers And Neurological Outcome in Neonates 2</brief_title>
  <acronym>BANON2</acronym>
  <official_title>Validation of Biomarkers of Adverse Neurologic Outcome in Newborns at Risk for Perinatal Brain Injury - Study on Neuro-developmental Follow-up at 2 Years A Prospective Multicenter Observational Study for Development of a Diagnostic Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InfanDx AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>InfanDx AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Follow-up of participants of BANON1 study at age of at least 2 years. BANON1&#xD;
      (ClinicalTrials.gov ID: NCT03357250): Validation of biomarkers based on 24 months&#xD;
      neuro-developmental outcome data in a human population for their ability to diagnose the&#xD;
      severity of neonatal asphyxia. These biomarkers linked to asphyxia have been identified in&#xD;
      animal studies and a preliminary human study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Follow-Up on neuro-developmental status of Study participants of BANON1. BANON1&#xD;
      (ClinicalTrials.gov ID: NCT03357250): The aim of the study is to validate the application of&#xD;
      combinations of several laboratory parameters in early postnatal blood samples, for&#xD;
      identification of infants, who will suffer from early abnormal neonatal neurological outcome,&#xD;
      in a population at risk. The population at risk is defined as term and late preterm (&gt;36&#xD;
      weeks of gestation) human infants following perinatal hypoxia-ischemia with or without&#xD;
      postnatal resuscitation, and where the combination of laboratory parameters is derived from a&#xD;
      preliminary study performed in Turkey (AAMBI) using a metabolomics approach.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 5, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>participants with normal neuro-developmental status</measure>
    <time_frame>up to 42 month age</time_frame>
    <description>all infants with normal neuro-developmental status</description>
  </primary_outcome>
  <primary_outcome>
    <measure>participants with potentially abnormal neuro-developmental status</measure>
    <time_frame>up to 42 month age</time_frame>
    <description>All infants who do not fulfill outcomes 1, 3 or 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>participants with abnormal neuro-developmental status - HIE</measure>
    <time_frame>up to 42 month age</time_frame>
    <description>Presence of adverse 2 years neuro-developmental outcome likely attributable to perinatal hypoxic-ischemic brain injury</description>
  </primary_outcome>
  <primary_outcome>
    <measure>participants with abnormal neuro-developmental status - non-HIE</measure>
    <time_frame>up to 42 month age</time_frame>
    <description>Presence of adverse 2 years neuro-developmental outcome not attributable to perinatal hypoxic-ischemic brain injury</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Asphyxia Neonatorum</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Children, who had been enrolled in the BANON study immediately after birth because they had&#xD;
        been suspected to be at risk for perinatal brain injury (hypoxic-ischemic encephalopathy,&#xD;
        HIE) and/or evaluated for hypothermia therapy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Infants previously enrolled in BANON study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Missing valid written informed parental consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Months</minimum_age>
    <maximum_age>48 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ron Meyer</last_name>
    <role>Study Director</role>
    <affiliation>InfanDx AG</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ron Meyer</last_name>
    <phone>+49 172 266 5552</phone>
    <email>ron.meyer@infandx.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carola Steins-Rang, Dr.</last_name>
    <phone>+49 22129271405</phone>
    <email>carola.steins-rang@infandx.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Städtisches Krankenhaus Aschaffenburg</name>
      <address>
        <city>Aschaffenburg</city>
        <zip>63739</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Wieg, Dr. med.</last_name>
      <email>christian.wieg@klinikum-ab-alz.de</email>
    </contact>
    <investigator>
      <last_name>Christian Wieg, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Carl Gustav Carus, Neonatologie</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Winkler, Dr. med.</last_name>
      <email>stefan.winkler@uniklinikum-dresden.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Winkler, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uniklinik Essen</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ursula Felderhoff, Prof.</last_name>
      <email>ursula.felderhoff@uk-essen.de</email>
    </contact>
    <investigator>
      <last_name>Ursula Felderhoff, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marienkrankenhaus</name>
      <address>
        <city>Hamburg</city>
        <zip>22149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lutz Koch, Prof.</last_name>
      <email>l.koch@KKH-Wilhelmstift.de</email>
    </contact>
    <investigator>
      <last_name>Lutz Koch, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Pöschl, Prof.</last_name>
      <email>johannes.poeschl@med.uni-heidelberg.de</email>
    </contact>
    <investigator>
      <last_name>Johannes Pöschl, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Karlsruhe, Klinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joachim Kühr, Prof.</last_name>
      <email>Joachim.Kuehr@klinikum-karlsruhe.de</email>
    </contact>
    <investigator>
      <last_name>Joachim Kühr, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Kinder- und Jugendmedizin, Klinikum Dritter Orden,</name>
      <address>
        <city>München</city>
        <zip>80638</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jochen Peters, Prof.</last_name>
      <email>J.Peters@dritter-orden.de</email>
    </contact>
    <investigator>
      <last_name>Jochen Peters, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitäts Kinderkrankenhaus und Perinatal Zentrum</name>
      <address>
        <city>München</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Flemmer, Prof.</last_name>
      <email>andreas.flemmer@med.uni-muenchen.de</email>
    </contact>
    <investigator>
      <last_name>Andreas Flemmer, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kinderklinik Dritter Orden</name>
      <address>
        <city>Passau</city>
        <zip>94032</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Keller, Prof.</last_name>
      <email>matthias.keller@kinderklinik-passau.de</email>
    </contact>
    <investigator>
      <last_name>Matthias Keller, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik St. Hedwig</name>
      <address>
        <city>Regensburg</city>
        <zip>93049</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jochen Kittel, Dr. med.</last_name>
      <email>Jochen.Kittel@barmherzige-regensburg.de</email>
    </contact>
    <investigator>
      <last_name>Jochen Kittel, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen, Universiätsklinik für Kinder- u. Jugendmedizin</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Franz, Prof.</last_name>
      <email>axel.franz@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Axel Franz, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cukurova University Hospital</name>
      <address>
        <city>Adana</city>
        <zip>01330</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hacer Yapicioglu-Yildizdas, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Hacer Yapicioglu-Yildizdas, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Firat, Department of Pediatrics</name>
      <address>
        <city>Elazığ</city>
        <zip>23040</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erdal Taskin, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Erdal Taskin, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 13, 2021</study_first_submitted>
  <study_first_submitted_qc>January 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2021</study_first_posted>
  <last_update_submitted>January 18, 2021</last_update_submitted>
  <last_update_submitted_qc>January 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biomarkers</keyword>
  <keyword>Asphyxia</keyword>
  <keyword>Hypoxic ischemic encephalopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asphyxia Neonatorum</mesh_term>
    <mesh_term>Asphyxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

